<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02612428</url>
  </required_header>
  <id_info>
    <org_study_id>VTL-308</org_study_id>
    <nct_id>NCT02612428</nct_id>
  </id_info>
  <brief_title>Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w/ AILD</brief_title>
  <official_title>A Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects With Alcohol-Induced Liver Decompensation (AILD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vital Therapies, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vital Therapies, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of the study is to evaluate safety and efficacy of ELAD with respect to
      overall survival of subjects with a clinical diagnosis of alcohol-induced liver
      decompensation (AILD) through at least Study Day 91.

      The secondary objective is to evaluate the proportion of survivors at Study Day 91 using a
      chi-squared test.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall survival</measure>
    <time_frame>91 days</time_frame>
    <description>Overall survival will be assessed using a Kaplan-Meier analysis of the Intent-to-Treat population, utilizing a log-rank test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of survivors</measure>
    <time_frame>91 days</time_frame>
    <description>A chi-square test will be used to evaluate the proportion of subjects who survived at end of study day 91</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Acute Alcoholic Hepatitis</condition>
  <arm_group>
    <arm_group_label>ELAD System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will receive treatment with ELAD plus standard of care therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care (Control)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>This group will receive standard of care therapy as defined in the protocol.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>ELAD System</intervention_name>
    <description>An extracorporeal human hepatic cell-based liver treatment</description>
    <arm_group_label>ELAD System</arm_group_label>
    <other_name>ELAD</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard of Care (Control)</intervention_name>
    <description>Standard medical treatment as defined by the protocol</description>
    <arm_group_label>Standard of Care (Control)</arm_group_label>
    <other_name>Standard of Care</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Subjects must meet ALL inclusion criteria to be eligible for the study:

          1. Age ≥18;

          2. Total bilirubin ≥16 mg/dL (≥273.6 µmol/L);

          3. A clinical diagnosis of alcohol-induced liver decompensation (AILD), based upon lab
             test or medical history or family interview with a causal relationship and temporal
             association (6 weeks or less) of alcohol use and hospital admission for this episode
             of AILD;

          4. Maddrey score ≥32;

          5. Subjects must have AILD that is severe acute alcoholic hepatitis (sAAH) diagnosed with
             either:

             a. A confirmatory liver biopsy, OR b. Two or more of the following: i. Hepatomegaly,
             ii. AST &gt; ALT, iii. Ascites, iv. Leukocytosis (WBC count above lab normal at site);

             Note: Subjects will be classified as either:

               1. AILD that is sAAH with no underlying liver disease other than alcoholic liver
                  disease, OR

               2. AILD that is sAAH with evidence of underlying liver disease other than alcoholic
                  liver disease which must be documented by:

             i. Liver biopsy, AND/OR ii. Laboratory findings, AND/OR iii. Medical history;

          6. Not eligible for liver transplant during this hospitalization;

          7. Subject or legally-authorized representative must provide Informed Consent;

          8. Subject must be eligible for Standard of Care treatment as defined in the protocol.

        Exclusion Criteria:

        Subjects must NOT have any of the exclusion criteria to be eligible for the study:

          1. Age ≥50;

          2. Platelet count &lt;40,000/mm3;

          3. International Normalization Ratio (INR) &gt;2.5;

          4. Serum Creatinine ≥1.3 mg/dL (≥115.04 µmol/L);

          5. MELD score ≥30;

          6. AST &gt;500 IU/L;

          7. Evidence of infection unresponsive to antibiotics (e.g. increased tissue involvement
             relative to initial diagnosis, clinical worsening of symptoms, etc.) indicated by any
             of the following:

               1. Presence of sepsis or septic shock; OR

               2. Positive blood cultures (bacteremia, fungemia) within 72 hours prior to
                  Randomization; OR

               3. Presence of spontaneous bacterial peritonitis during the 2 days prior to
                  Randomization; OR

               4. Clinical and radiological signs of pneumonia;

          8. Evidence of reduction in total bilirubin of 20% or more in the previous 72 hours.
             Bilirubin measurements must be taken at least 12 hours after any procedure known to
             artificially alter serum bilirubin (e.g., administration of packed red blood cells,
             plasma exchange);

          9. Evidence of hemodynamic instability as defined by the following:

               1. Systolic blood pressure &lt;90 mmHg with evidence of diminished perfusion
                  unresponsive to fluid resuscitation and/or low-dose pressor support; OR

               2. Mean arterial pressure (MAP) &lt;60 mmHg with evidence of diminished perfusion
                  unresponsive to fluid resuscitation and/or low-dose pressor support; OR

               3. Requirement for escalating doses of vasopressor support prior to Screening; OR

               4. Subject on vasopressors, including but not limited to those listed below, at
                  doses above the following at Screening or Randomization:

                    -  Dobutamine: 5.0 µg/kg/min

                    -  Dopamine: 2.0 µg/kg/min

                    -  Norepinephrine: 0.02 µg/kg/min

                    -  Phenylephrine: 1.0 µg/kg/min

                    -  Vasopressin: 0.02 U/min

         10. Evidence of active bleeding, major hemorrhage defined as requiring ≥2 units packed red
             blood cells to maintain a stable hemoglobin occurring within 48 hours prior to
             Randomization, or with banding of gastroesophageal varices during the 7 days
             immediately preceding screening;

         11. Clinical evidence of liver size reduction due to cirrhosis [liver size of the
             craniocaudal diameter (sagittal view) &lt;10 cm when measured on the mid clavicular line
             (or equivalent measurement) by ultrasound, or liver volume &lt;1200 cc as determined by
             CT or MRI], unless Investigator interpretation of the clinical evidence indicates
             liver size of &lt;10 cm or volume &lt;1200 cc is not considered reduced for the individual
             subject, and Sponsor agrees;

         12. Occlusive portal vein thrombosis impairing hepatopetal flow, or evidence of bile duct
             obstruction;

         13. Evidence by physical exam, history, or laboratory evaluation, of significant
             concomitant disease with a life expectancy of less than 3 months, including, but not
             limited to:

               1. Severe acute or chronic cardiovascular, central nervous system, or pulmonary
                  disease;

               2. Cancer that has metastasized or has not yet been treated;

               3. Severe metabolic abnormalities that have not been corrected (See Section 5.1.3);

         14. Subject has chronic end-stage renal disease requiring chronic hemodialysis for more
             than 8 weeks (not classified as hepatorenal syndrome);

         15. Subject ventilated or intubated;

         16. Subject on hemodialysis;

         17. Subject has liver disease related to homozygous hemachromotosis, Wilson's disease, has
             non-alcoholic fatty liver disease, or Budd-Chiari Syndrome;

         18. Serological evidence (including viral titers) of active viral hepatitis A, B or C
             infection. If the investigator suspects that the subject may be at risk for viral
             hepatitis A, B or C, and no serology is available, then serologies must be obtained
             prior to Randomization, as a positive serology would be exclusionary;

         19. Pregnancy as determined by serum β-human chorionic gonadotropin (HCG) results, or
             subjects of child-bearing potential not willing to use effective means of
             contraception, without history of medical or surgical sterilization;

         20. Participation in another investigational drug, biologic, or device study within one
             month of enrollment, except for observational studies (the observational study setting
             should not affect the safety and/or efficacy of the VTL-308 clinical trial);

         21. Previous liver transplant;

         22. Previous enrollment in the treatment phase of another ELAD trial;

         23. Have a Do Not Resuscitate or a Do Not Intubate (DNR/DNI) directive (or such local
             equivalent) or any other Advanced Directive limiting Standard of Care in place (the
             DNR/DNI criterion is not applicable in Europe);

         24. Refusal to participate in the VTL-308E follow-up study;

         25. Inability to provide an address for home visits.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Stange, MD</last_name>
    <role>Study Director</role>
    <affiliation>Vital Therapies, Inc.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Reich, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>PA - Drexel University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lance Stein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>GA - Piedmont Atlanta Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nikolaos Pyrsopoulos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NJ - Rutgers University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Valentin Cuervas-Mons, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spain - Hospital Universitario Puerta de Hierro Majadahonda</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Raza Malik, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MA - Beth Israel Deaconess Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nikunj Shah, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IL - Rush University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Simona Rossi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>PA - Albert Einstein Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Juan Caballeria, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spain - Hospital Clinic de Barcelona</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ram Subramanian, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>GA - Emory University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andres Duarte-Rojo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AR - University of Arkansas for Medical Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Julie Thompson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MN - University of Minnesota</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter R Galle, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Germany - Universitätsmedizin Mainz</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hartmut H.-J. Schmidt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Germany - Universitätsklinikum Münster</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Markus Busch, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Germany - Medizinische Hochschule Hannover</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kristina Chacko, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NY - Montefiore Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Talal Adhami, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>OH - Cleveland Clinic Foundation</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Constance Mobley, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>TX - Houston Methodist Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David J Kramer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>WI - Aurora St. Luke's Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stephen Caldwell, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA - University of Virginia Health System</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ali Al-Khafaji, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>PA - University of Pittsburgh Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kalyan R Bhamidimarri, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>FL - Schiff Center for Liver Diseases/University of Miami</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Manuel Romero-Gomez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spain - Hospital Universitario Virgen del Rocío</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tarek Hassanein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CA - Sharp Coronado Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Waldo Concepcion, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CA - Stanford University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Martin Prieto Castillo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spain - Hospital Universitario y Politécnico La Fe</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rafael Bañares, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spain - Hospital Universitario Gregorio Marañón</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Syed Naqvi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MO - University of Missouri Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Matthias Dollinger, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Germany - Klinikum Landshut gemeinnuetzige GmbH</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Karen Krok, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>PA - The Pennsylvania State University and The Milton S. Hershey Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rudolf Stauber, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Austria - Medizinische Universität Graz</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christian Zauner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Austria - Medizinische Universität Klinik Für Innere Medizin III</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Georg Lamprecht, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Germany - Universitätsmedizin Rostock</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paul Thuluvath, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MD - Mercy Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Trinidad Serrano Aullo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spain - Hospital Clínico Universitario Lozano Blesa</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael Stephens, PhD</last_name>
    <phone>858-924-1991</phone>
    <email>mstephens@vitaltherapies.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Brian Dempster</last_name>
    <phone>858-649-1814</phone>
    <email>bdempster@vitaltherapies.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Arkansas for Medical Sciences</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andres Duarte-Rojo, MD</last_name>
      <phone>501-686-5177</phone>
      <email>aduarterojo@uams.edu</email>
    </contact>
    <contact_backup>
      <last_name>Mauricio Garcia Saenz de Sicilia, MD</last_name>
      <phone>(501) 686-5177</phone>
      <email>mgarcia@uams.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Andres Duarte-Rojo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sharp Coronado Hospital</name>
      <address>
        <city>Coronado</city>
        <state>California</state>
        <zip>92118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tarek Hassanein, MD</last_name>
      <phone>619-522-0330</phone>
    </contact>
    <investigator>
      <last_name>Tarek Hassanein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University Medical Center</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Waldo Concepcion, MD</last_name>
      <phone>650-723-5454</phone>
      <email>WConcepcion@stanfordhealthcare.org</email>
    </contact>
    <contact_backup>
      <last_name>Radhika Kumari, MD</last_name>
      <phone>909-728-7113</phone>
      <email>rkumari@stanford.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Waldo Concepcion, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Schiff Center for Liver Diseases/University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Elibero, RN BSN CCRC</last_name>
      <phone>305-243-6968</phone>
      <email>axe375@med.miami.edu</email>
    </contact>
    <contact_backup>
      <last_name>Kaylan R Bhamidimarri, MD MPH</last_name>
      <phone>305-243-3333</phone>
      <email>KBhamidimarri@med.miami.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Kaylan R Bhamidimarri, MD MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Piedmont Atlanta Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bethany Lane, RN,MSN,CCRC</last_name>
      <phone>404-605-4618</phone>
      <email>bethany.lane@piedmont.org</email>
    </contact>
    <contact_backup>
      <last_name>Joy Burnette, RN,BSN,CRC</last_name>
      <phone>404-605-3212</phone>
      <email>joy.burnette@piedmont.org</email>
    </contact_backup>
    <investigator>
      <last_name>Lance Stein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ram Subramanian, MD</last_name>
      <phone>404-712-1816</phone>
      <email>rmsubra@emory.edu</email>
    </contact>
    <contact_backup>
      <last_name>Donna Kang, RN, BSN</last_name>
      <phone>404-712-4260</phone>
      <email>Donna.Lee.Kang@emory.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Ram Subramanian, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diana Giczewski, RN, MS, BSN</last_name>
      <phone>312-563-3919</phone>
      <email>Diana_Giczewski@rush.edu</email>
    </contact>
    <contact_backup>
      <last_name>Lelani Fetrow</last_name>
      <phone>312-942-1372</phone>
      <email>Lelani_C_Fetrow@rush.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Nikunj Shah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mercy Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sung Cho</last_name>
      <phone>410-576-5389</phone>
      <email>scho@mdmercy.com</email>
    </contact>
    <investigator>
      <last_name>Paul Thuluvath, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raza Malik, MD</last_name>
      <phone>617-632-1070</phone>
    </contact>
    <contact_backup>
      <last_name>Susan McDermott, MPH, RN</last_name>
      <phone>617-632-9841</phone>
    </contact_backup>
    <investigator>
      <last_name>Raza Malik, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Scott Rajala</last_name>
      <phone>612-626-8511</phone>
      <email>srajala@umn.edu</email>
    </contact>
    <contact_backup>
      <last_name>Julie Thompson, MD</last_name>
      <email>thom0235@umn.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Julie Thompson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Missouri Hospital</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Syed Naqvi, MD</last_name>
      <phone>573-884-9075</phone>
    </contact>
    <investigator>
      <last_name>Syed Naqvi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rutgers University Hospital</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nikolaos Pyrsopoulos, MD</last_name>
      <phone>973-972-5252</phone>
      <email>pyrsopni@njms.rutgers.edu</email>
    </contact>
    <contact_backup>
      <last_name>Serban A Moroianu</last_name>
      <phone>973-972-0130</phone>
      <email>moroiasa@njms.rutgers.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Nikolaos Pyrsopoulos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>The Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristina Chacko, MD</last_name>
      <phone>718-920-7561</phone>
      <email>krchacko@montefiore.org</email>
    </contact>
    <contact_backup>
      <last_name>Alana Zanetti-Yabur</last_name>
      <email>alana.zanetti-yabur@einstein.yu.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Kristina Chacko, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cynthia Wiley-Wade</last_name>
      <phone>216-444-2084</phone>
      <email>wileywc@ccf.org</email>
    </contact>
    <contact_backup>
      <last_name>Margaret Terry</last_name>
      <phone>216-445-4790</phone>
      <email>terrym@ccf.org</email>
    </contact_backup>
    <investigator>
      <last_name>Talal Adhami, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Pennsylvania State University and The Milton S. Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Krok, MD</last_name>
      <phone>717-531-1017</phone>
      <email>KKrok@pennstatehealth.psu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Laurie Peiffer, RCC</last_name>
      <phone>717-531-5226</phone>
      <email>lpeiffer@pennstatehealth.psu.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Karen Krok, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Drexel University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cynthia Gifford-Hollingsworth, DrNP, CRNP</last_name>
      <phone>267-507-6811</phone>
      <email>Cgiffor1@drexelmed.edu</email>
    </contact>
    <contact_backup>
      <last_name>David Reich, MD</last_name>
      <phone>215-762-3900</phone>
      <email>david.reich@drexelmed.edu</email>
    </contact_backup>
    <investigator>
      <last_name>David Reich, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Albert Einstein Medical Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19141</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marva James, RN,MHS,CCRN</last_name>
      <phone>215-456-2004</phone>
      <email>JamesMar@einstein.edu</email>
    </contact>
    <contact_backup>
      <last_name>Stacey Carmody</last_name>
      <phone>215-456-7534</phone>
      <email>CarmodyS@einstein.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Simona Rossi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15261</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Kruth, RN CRC</last_name>
      <phone>412-647-3855</phone>
      <email>kruthm@upmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Mary Stefanick, RN BSN CCRC</last_name>
      <phone>412-802-6746</phone>
      <email>stefanickma@upmc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Ali Al-Khafaji, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Houston Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Constance Mobley, MD, PhD</last_name>
      <phone>713-441-1590</phone>
      <email>cmmobley@houstonmethodist.org</email>
    </contact>
    <contact_backup>
      <last_name>Melissa Whipple, RN</last_name>
      <phone>713-441-3247</phone>
      <email>mbwhipple@houstonmethodist.org</email>
    </contact_backup>
    <investigator>
      <last_name>Constance Mobley, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Virginia Health System</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jaye Davis, RN</last_name>
      <phone>434-924-1784</phone>
      <email>jbd3g@eservices.virginia.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jennifer A Greene, RN BSN CCRC</last_name>
      <phone>434-982-0709</phone>
      <email>JAG7FH@hscmail.mcc.virginia.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Stephen Caldwell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aurora St. Luke's Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lynda Yanny, RN BSN CCRC</last_name>
      <phone>414-649-6685</phone>
      <email>lynda.yanny@aurora.org</email>
    </contact>
    <contact_backup>
      <last_name>Mary Briggs-Sedlachek, RN</last_name>
      <phone>414-219-4873</phone>
      <email>mary.briggs-sedlachek@aurora.org</email>
    </contact_backup>
    <investigator>
      <last_name>David J Kramer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medizinische Universität Graz</name>
      <address>
        <city>Graz</city>
        <state>Styria</state>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rudolf Stauber, MD</last_name>
      <phone>+43-316-385-80268</phone>
      <email>rudolf.stauber@medunigraz.at</email>
    </contact>
    <investigator>
      <last_name>Rudolf Stauber, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medizinische Universität Klinik Für Innere Medizin III</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Zauner, MD</last_name>
      <phone>+43 1 40400 47670</phone>
      <email>christian.zauner@meduniwien.ac.at</email>
    </contact>
    <contact_backup>
      <last_name>Monika Schmid</last_name>
      <phone>+43 1 40400 47670</phone>
      <email>monika.schmid@meduniwien.ac.at</email>
    </contact_backup>
    <investigator>
      <last_name>Christian Zauner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Landshut gemeinnuetzige GmbH</name>
      <address>
        <city>Landshut</city>
        <state>Bavaria</state>
        <zip>84034</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthias Dollinger, MD, PhD</last_name>
      <phone>+49 (0)871 698 3717</phone>
      <email>matthias.dollinger@klinikum-landshut.de</email>
    </contact>
    <investigator>
      <last_name>Matthias Dollinger, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>D-30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Markus Busch, MD</last_name>
      <phone>+49 511 532 7623</phone>
      <email>busch.markus@mh-hannover.de</email>
    </contact>
    <contact_backup>
      <last_name>Hans Heinrich Wedemeyer, MD</last_name>
      <phone>+49 511 532 6814</phone>
      <email>wedemeyer.heiner@mh-hannover.de</email>
    </contact_backup>
    <investigator>
      <last_name>Markus Busch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Mainz</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oliver Schreiner, MD</last_name>
      <phone>06131 17-2613/17-7103</phone>
      <email>Oliver.Schreiner@unimedizin-mainz.de</email>
    </contact>
    <contact_backup>
      <last_name>Peter R Galle, MD</last_name>
      <phone>06131 17-2613/17-6831</phone>
      <email>Peter.Galle@unimedizin-mainz.de</email>
    </contact_backup>
    <investigator>
      <last_name>Peter R Galle, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Münster</name>
      <address>
        <city>Münster</city>
        <zip>D-48149</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Wilms, MD</last_name>
      <phone>+49 251 83 57935</phone>
      <email>christian.wilms@ukmuenster.de</email>
    </contact>
    <contact_backup>
      <last_name>Hartmut Schmidt, MD</last_name>
      <phone>+49 251 83 57935</phone>
      <email>hepar@ukmuenster.de</email>
    </contact_backup>
    <investigator>
      <last_name>Hartmut Schmidt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Rostock</name>
      <address>
        <city>Rostock</city>
        <zip>D-18065</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georg Lamprecht, MD</last_name>
      <phone>+49 381 494 7481</phone>
      <email>Georg.Lamprecht@med.uni-rostock.de</email>
    </contact>
    <investigator>
      <last_name>Georg Lamprecht, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Belfast Health and Social Care Trust</name>
      <address>
        <city>Belfast</city>
        <zip>BT9 7AB</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>0044 (0) 28 9024 0503</phone>
    </contact>
    <contact_backup>
      <phone>www.belfasttrust.hscni.net</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>St. Vincent's University Hospital</name>
      <address>
        <city>Dublin</city>
        <zip>Dublin 4</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>00353 1 2214117</phone>
    </contact>
    <contact_backup>
      <phone>www.stvincents.ie</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Puerta de Hierro Majadahonda</name>
      <address>
        <city>Majadahonda</city>
        <state>Madrid</state>
        <zip>28222</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valentin Cuervas-Mons, MD</last_name>
      <phone>+34911917341</phone>
      <email>valentin.cuervasmons@uam.es</email>
    </contact>
    <investigator>
      <last_name>Valentin Cuervas-Mons, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Caballeria, MD</last_name>
      <phone>+34 93 227 57 53</phone>
      <email>CABALLER@clinic.cat</email>
    </contact>
    <investigator>
      <last_name>Juan Caballeria, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Gregorio Marañón</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rafael Bañares, MD</last_name>
      <phone>+34 91 586 83 08</phone>
      <email>rafael.banares@salud.madrid.org</email>
    </contact>
    <investigator>
      <last_name>Rafael Bañares, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen del Rocío</name>
      <address>
        <city>Sevilla</city>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manuel Romero-Gomez, MD</last_name>
      <phone>+34 600 162 875</phone>
      <email>mromerog@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Manuel Romero-Gomez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario y Politécnico La Fe</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Prieto Castillo, MD</last_name>
      <phone>+34 961 245 859</phone>
      <email>mprietoc@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Martin Prieto Castillo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario Lozano Blesa</name>
      <address>
        <city>Zaragoza</city>
        <zip>50009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Trinidad Serrano Aullo, MD</last_name>
      <phone>+34 976 55 64 00</phone>
      <phone_ext>162454</phone_ext>
      <email>tserrano.aullo@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Trinidad Serrano Aullo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aintree University Hospital</name>
      <address>
        <city>Liverpool</city>
        <state>England</state>
        <zip>L97AL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>01515255980</phone>
    </contact>
    <contact_backup>
      <phone>www.aintreehospital.nhs.uk</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ninewells Hospital and Medical School</name>
      <address>
        <city>Dundee</city>
        <state>Scotland</state>
        <zip>DD1 9SY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>01382 660111</phone>
    </contact>
    <contact_backup>
      <last_name>www.nhstayside.scot.nhs.uk</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Glasgow Royal Infirmary</name>
      <address>
        <city>Glasgow</city>
        <state>Scotland</state>
        <zip>G40SF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>0141 211 4000</phone>
    </contact>
    <contact_backup>
      <phone>www.nhsggc.org.uk</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth Hospital</name>
      <address>
        <city>Birmingham</city>
        <zip>B15 2GW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>0121 627 2000</phone>
    </contact>
    <contact_backup>
      <phone>www.@uhb.nhs.uk</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Doncaster Royal Infirmary</name>
      <address>
        <city>Doncaster</city>
        <zip>DN2 5LT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>01302 366666</phone>
    </contact>
    <contact_backup>
      <phone>www.dbh.nhs.uk</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Royal London Hospital</name>
      <address>
        <city>London</city>
        <zip>E1 1BB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+44 20 3594 6773</phone>
    </contact>
    <contact_backup>
      <phone>www.bartshealth.nhs.uk</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Royal Free Hospital</name>
      <address>
        <city>London</city>
        <zip>NW3 2QG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>020 7794 0500</phone>
    </contact>
    <contact_backup>
      <phone>www.@ucl.ac.uk</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Nottingham University Hospital</name>
      <address>
        <city>Nottingham</city>
        <zip>NG7 2UH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>0115 924 9924</phone>
    </contact>
    <contact_backup>
      <phone>www.nuhrise.org</phone>
    </contact_backup>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Germany</country>
    <country>Ireland</country>
    <country>Spain</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://vitaltherapies.com</url>
    <description>Company website</description>
  </link>
  <link>
    <url>https://aahstudy.com</url>
    <description>A screening tool for referring physicians to see if a patient may qualify for VTL-308. The referring physician is asked to input pertinent lab values and medical condition to determine whether or not patients may qualify for VTL-308.</description>
  </link>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 19, 2015</study_first_submitted>
  <study_first_submitted_qc>November 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 23, 2015</study_first_posted>
  <last_update_submitted>November 2, 2017</last_update_submitted>
  <last_update_submitted_qc>November 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis, Alcoholic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

